RxSight, Inc. Common Stock (RXST)

Price$5.00

Value ScoreB

Growth ScoreC

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-64.14%

Price vs S&P 500 (4W)-14.52%

VGM Score45.39

Market Capitalization$206.98M

All Metrics

Book Value / Share (Quarterly)$6.46

P/TBV (Annual)11.72x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)40.00%

Cash Flow / Share (Quarterly)$-0.52

Price vs S&P 500 (YTD)-60.17%

Gross Margin (TTM)77.02%

Net Profit Margin (TTM)-36.59%

EPS (TTM)$-1.14

10-Day Avg Trading Volume0.97M

EPS Excl Extra (TTM)$-1.14

Revenue Growth (5Y)55.73%

EPS (Annual)$-0.95

ROI (Annual)-14.12%

Gross Margin (Annual)76.60%

Net Profit Margin (5Y Avg)-90.98%

Cash / Share (Quarterly)$5.26

Revenue Growth QoQ (YoY)-18.48%

ROA (Last FY)-12.49%

Revenue Growth TTM (YoY)-14.05%

EBITD / Share (TTM)$-1.27

ROE (5Y Avg)-32.74%

Operating Margin (TTM)-43.42%

Cash Flow / Share (Annual)$-0.47

P/B Ratio0.77x

P/B Ratio (Quarterly)0.95x

Net Income / Employee (Annual)$-84,500

EV / Revenue (TTM)1.49x

Net Interest Coverage (TTM)-18.46x

ROA (TTM)-15.13%

EPS Incl Extra (Annual)$-0.95

Current Ratio (Annual)10.95x

Quick Ratio (Quarterly)8.78x

3-Month Avg Trading Volume0.85M

52-Week Price Return-66.49%

Revenue / Employee (TTM)$276,500

Tangible BV / Share (Quarterly)$4.50

P/S Ratio (Annual)1.54x

Asset Turnover (Annual)0.43x

52-Week High$16.00

Operating Margin (5Y Avg)-96.66%

EPS Excl Extra (Annual)$-0.95

CapEx CAGR (5Y)8.56%

26-Week Price Return-56.22%

Quick Ratio (Annual)9.58x

13-Week Price Return-35.98%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)10.20x

Enterprise Value$189.50M

Revenue / Share Growth (5Y)42.59%

Asset Turnover (TTM)0.41x

Revenue / Employee (Annual)$291,700

Inventory Turnover (Annual)1.18x

Pretax Margin (Annual)-28.91%

Cash / Share (Annual)$5.53

3-Month Return Std Dev63.11%

Gross Margin (5Y Avg)54.24%

Net Income / Employee (TTM)$-101,200

ROE (Last FY)-14.13%

Net Interest Coverage (Annual)-23.56x

EPS Basic Excl Extra (Annual)$-0.95

Receivables Turnover (TTM)4.77x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.14

Receivables Turnover (Annual)5.03x

ROI (TTM)-17.00%

P/S Ratio (TTM)1.62x

Pretax Margin (5Y Avg)-90.95%

Revenue / Share (Annual)$3.29

Tangible BV / Share (Annual)$3.18

Price vs S&P 500 (52W)-90.85%

Year-to-Date Return-52.02%

5-Day Price Return-4.58%

EPS Normalized (Annual)$-0.95

ROA (5Y Avg)-23.49%

Net Profit Margin (Annual)-28.96%

Month-to-Date Return-6.19%

Cash Flow / Share (TTM)$-1.54

EBITD / Share (Annual)$-1.18

Operating Margin (Annual)-35.84%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-26.55%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.14

P/TBV (Quarterly)6.52x

P/B Ratio (Annual)1.55x

Inventory Turnover (TTM)1.00x

Pretax Margin (TTM)-36.54%

Book Value / Share (Annual)$6.68

Price vs S&P 500 (13W)-44.23%

Beta1.16x

Revenue / Share (TTM)$3.09

ROE (TTM)-17.01%

52-Week Low$4.70

vGradeB

gGradeC

mGradeF

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.38est. -0.29

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

2.63

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
RXSTRxSight, Inc. Common Stock	B	C	F	$5.00
ALCAlcon Inc. Ordinary Shares	C	C	C	$66.81
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$67.34
BLCOBausch + Lomb Corporation	B	C	C	$15.46
WRBYWarby Parker Inc.	D	B	C	$22.72
STAAStaar Surgical Co	D	C	A	$29.99
EYENational Vision Holdings, Inc. Common Stock	A	D	D	$15.44
LUCYInnovative Eyewear, Inc. Common Stock	A	A	D	$0.91
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	C	$0.05

About

RxSight Inc is a medical technology company specializing in light adjustable intraocular lenses for cataract surgery. Its proprietary technology allows surgeons to customize and optimize patient vision outcomes post-surgery, reducing the need for corrective eyewear and improving patient satisfaction. The company manufactures light adjustable lenses and related capital equipment for the ophthalmology market.